These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11926381)

  • 1. A method for measurement of the uptake patterns of two beta-emitting radionuclides in the same tissue section with a digital silicon detector: application to a study of 89SrCl2 and 153Sm-EDTMP in a dog with spontaneous osteosarcoma.
    Kvinnsland Y; Bruland O; Moe L; Skretting A
    Eur J Nucl Med Mol Imaging; 2002 Feb; 29(2):191-7. PubMed ID: 11926381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 153Sm-EDTMP and (89)SrCl(2) in a dog with spontaneous osteosarcoma.
    Lass P; Scheffler J
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1414; author reply 1415. PubMed ID: 12271428
    [No Abstract]   [Full Text] [Related]  

  • 3. Predicting detectability in radioguided surgery: a study based on physical characterization of the probe and on tissue uptake ratios of 125I-, 153Sm- and 165Er-labelled radiopharmaceuticals.
    Hassfjell SP; Skretting A; Bruland OS; Hoff P
    Nucl Med Commun; 1998 Mar; 19(3):207-17. PubMed ID: 9625495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease.
    Brenner W; Kampen WU; Kampen AM; Henze E
    J Nucl Med; 2001 Feb; 42(2):230-6. PubMed ID: 11216521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation safety considerations for the bone seeking radiopharmaceuticals. 89SrCl2, 186Re-HEDP and 153Sm-EDTMP.
    Lam MG; Hoekstra A; de Klerk JM; van Rijk PP; Zonnenberg BA
    Nuklearmedizin; 2009; 48(1):37-43. PubMed ID: 19212610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maxillectomy and targeted radionuclide therapy with 153Sm-EDTMP in a recurrent canine osteosarcoma.
    Moe L; Boysen M; Aas M; Lønaas L; Gamlem H; Bruland OS
    J Small Anim Pract; 1996 May; 37(5):241-6. PubMed ID: 8736231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (99m)Tc-MDP uptake in soft-tissue osteosarcoma in a dog.
    Lass P; Krzemiński M; Teodorczyk J
    Nucl Med Rev Cent East Eur; 2004; 7(2):189. PubMed ID: 15968610
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeted radiotherapy with Sm-153-EDTMP in nine cases of canine primary bone tumours.
    Milner RJ; Dormehl I; Louw WK; Croft S
    J S Afr Vet Assoc; 1998 Mar; 69(1):12-7. PubMed ID: 9646255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of samarium-153 and holmium-166-EDTMP in the normal baboon model.
    Louw WK; Dormehl IC; van Rensburg AJ; Hugo N; Alberts AS; Forsyth OE; Beverley G; Sweetlove MA; Marais J; Lötter MG; van Aswegen A
    Nucl Med Biol; 1996 Nov; 23(8):935-40. PubMed ID: 9004281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraorgan biodistribution and dosimetry of 153Sm-ethylenediaminetetramethylene phosphonate in juvenile rabbit tibia: implications for targeted radiotherapy of osteosarcoma.
    Essman SC; Lewis MR; Miller WH
    J Nucl Med; 2005 Dec; 46(12):2076-82. PubMed ID: 16330573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P
    Expert Opin Pharmacother; 2006 Aug; 7(11):1475-86. PubMed ID: 16859431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying the radiation dosage to individual skeletal lesions treated with samarium-153-EDTMP.
    van Rensburg AJ; Alberts AS; Louw WK
    J Nucl Med; 1998 Dec; 39(12):2110-5. PubMed ID: 9867152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
    Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
    J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of 188Re-HEDP, 186Re-HEDP, 153Sm-EDTMP and 89Sr in the treatment of painful skeletal metastases.
    Liepe K; Kotzerke J
    Nucl Med Commun; 2007 Aug; 28(8):623-30. PubMed ID: 17625384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of biological characteristics of EDTMP complexes with 99mTc, 111In and 153Sm in rats.
    Láznícek M; Láznícková A; Budský F; Prokop J; Kopicka K
    Appl Radiat Isot; 1994 Sep; 45(9):949-53. PubMed ID: 7951182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM; Subbiah V; Rohren E
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH; Martindale AA; Sorby P; Hetherington EL; Fleay RF; Hoffman RF; Claringbold PG
    Eur J Nucl Med; 1989; 15(12):784-95. PubMed ID: 2483138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.
    Garnuszek P; Pawlak D; Licińska I; Kamińska A
    Appl Radiat Isot; 2003 Apr; 58(4):481-8. PubMed ID: 12672628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Samarium 153Sm lexidronam.
    Lamb HM; Faulds D
    Drugs Aging; 1997 Nov; 11(5):413-8; discussion 419. PubMed ID: 9359026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.